Shilpa Medicare submits new drug application to USFDA for kidney disease treatment, stock hits all-time high
Shilpa Medicare Share Price | Shilpa Medicare submitted the NDA to the USFDA by Unicycive Therapeutics, its first regulatory submission from CDMO partnered projects.